Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-0743
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial ; volume:37 ; number:10 ; day:21 ; month:8 ; year:2021 ; pages:2815-2826 ; date:10.2021
The international journal of cardiovascular imaging ; 37, Heft 10 (21.8.2021), 2815-2826, 10.2021

Urheber
Rai, Himanshu
Alfonso, Fernando
Maeng, Michael
Bradaric, Christian
Wiebe, Jens
Cuesta, Javier
Christiansen, Evald Høj
Cassese, Salvatore
Hoppmann, Petra
Colleran, Roisin
Harzer, Fiona
Bresha, Jola
Nano, Nejva
Schneider, Simon
Laugwitz, Karl-Ludwig
Joner, Michael
Kastrati, Adnan
Byrne, Robert A.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s10554-021-02251-x
URN
urn:nbn:de:101:1-2021122321163850951319
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:37 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Rai, Himanshu
  • Alfonso, Fernando
  • Maeng, Michael
  • Bradaric, Christian
  • Wiebe, Jens
  • Cuesta, Javier
  • Christiansen, Evald Høj
  • Cassese, Salvatore
  • Hoppmann, Petra
  • Colleran, Roisin
  • Harzer, Fiona
  • Bresha, Jola
  • Nano, Nejva
  • Schneider, Simon
  • Laugwitz, Karl-Ludwig
  • Joner, Michael
  • Kastrati, Adnan
  • Byrne, Robert A.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents

Hochschulschrift

Inzidenz und Prädiktoren der Stentthrombose in Bare-Metal-Stents und Drug-Eluting-Stents

Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent

Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent

Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions

Conformability in everolimus-eluting bioresorbable scaffolds compared with metal platform coronary stents in long lesions

Niedrigdosierte Paclitaxel-freisetzende Ballone gegen konventionelle Paclitaxel-freisetzende Ballone zur Therapie von Drug-Eluting-Stent- Restenosen bei Patienten mit koronarer Herzkrankheit

Niedrigdosierte Paclitaxel-freisetzende Ballone gegen konventionelle Paclitaxel-freisetzende Ballone zur Therapie von Drug-Eluting-Stent- Restenosen bei Patienten mit koronarer Herzkrankheit

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Coronary Restenosis and Arterial Healing Following Drug-Eluting Stent Implantation – Time Course, Angiographic Metrics and Impact of Modifications in Polymer and Drug Coatings

Hochschulschrift

Coronary Restenosis and Arterial Healing Following Drug-Eluting Stent Implantation – Time Course, Angiographic Metrics and Impact of Modifications in Polymer and Drug Coatings

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience

Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation

Five‐year follow‐up of patients who underwent everolimus‐eluting bioresorbable scaffold implantation

Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry

Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry

Determinants of Clinical Outcomes Following Drug-Eluting Stent Implantation: Temporal Course, Mechanisms and Optical Characteristics of Stent Failure

Determinants of Clinical Outcomes Following Drug-Eluting Stent Implantation: Temporal Course, Mechanisms and Optical Characteristics of Stent Failure

Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium

Outcomes of 10,312 patients treated with everolimus‐eluting bioresorbable scaffolds during daily clinical practice – results from the European Absorb Consortium

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry

Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry

Verbundene Objekte